Navigation Links
Sanofi Pasteur Receives Seed Virus to Produce New Influenza A(H1N1) Vaccine
Date:5/27/2009

- Company to take first steps toward large-scale production -

SWIFTWATER, Pa. and LYON, France, May 27 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today it has received the new influenza A(H1N1) seed virus, enabling the world's leading manufacturer of influenza vaccines to begin the production process for an A(H1N1) vaccine.

The emergence of a new influenza A(H1N1) virus strain recently led the World Health Organization (WHO) to declare a Level 5 pandemic alert, following human-to-human spread of the virus into at least two countries in one WHO region.

"As a company committed to protecting human health, Sanofi Pasteur looks forward to quickly understanding how this virus performs in a vaccine manufacturing environment and developing a working seed that will enable large-scale production," said Wayne Pisano, President and CEO of Sanofi Pasteur. "This is an important step for engaging Sanofi Pasteur's resources and expertise to support public health authorities and the directives they provide us."

Receipt of the seed virus means that Sanofi Pasteur will begin the development process, called "passaging," that will yield a "working seed." Passaging is the process for acclimating virus to grow in a production environment at optimum yield. The passaging process is expected to take approximately two weeks. Following quality controls, Sanofi Pasteur will be prepared to begin industrial production as soon as directed by public health agencies.

Sanofi Pasteur operates influenza vaccine production facilities in Swiftwater, Pa. and Val de Reuil, France.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and dist
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
2. BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventis
3. AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
4. Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of all Infants
5. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
6. Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
7. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season
8. ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
9. U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile
10. Sanofi Pasteur Mounts Emergency Response to Yellow Fever Epidemic in Latin America
11. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)Alberta Centre for Advanced Micro Nano Technology Products (ACAMP) hosts, health & medical seminar, , EDMONTON, Dec. 4 /PRNewswire/ - Today ACAMP hosted a health & medical seminar, explaini
(Date:12/3/2009)MELVILLE, N.Y., Dec. 3 Nikon Corporation, an innovator of advanced optical instruments, announced today that it has signed a licensing agreement with Harvard University granting Nikon the rights to u
(Date:12/3/2009)TUSTIN, Calif., Dec. 3 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that it will release its financial results for the second quarter of fiscal year 2010 on December 10, 2009 at 7
(Date:12/2/2009)COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approx
Breaking Biology Technology:Alberta companies delivering new products to the health & medical marketplace 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2
...21 NovaRx Corporation announced today,that the co...al of,Lucanix(R) (belagenpumatucel-L) in the treat...). The first patient enrolled in the study was tre...al investigator at the University,of California, S....newscom.com/cgi-bin/prnh/20080821/LATH009-a ), (...
...uctor silicon and the ferromagnet iron are the bas...thing from computers to electric motors. In this w...an international group of scientists, including ac... and Lesotho, report that they have combined these...tal, manganese, to create a new material which is ...
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq...d a letter from The Nasdaq,Stock Market on August ...ly,with the requirements for continued listing on ...the maintenance standard that specifies, among,oth...n,s common stock be at,least $50 million as requir...
Other Biology Technology:NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 2NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 3NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients 4Creating unconventional metals 2Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market 2Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market 3
(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
(Date:12/3/2009)In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to dege
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2How nutrition affects healthy aging 2Papillomavirus silences innate immune response 2Hospital Workers May Trigger Dangerous Outbreaks 59765 1Hospital Workers May Trigger Dangerous Outbreaks 59765 2Hospital Workers May Trigger Dangerous Outbreaks 59765 3Detecting the undetectable in prostate cancer screening 59761 1Detecting the undetectable in prostate cancer screening 59761 2Detecting the undetectable in prostate cancer screening 59761 3Detecting the undetectable in prostate cancer screening 59761 4GSA showcases groundbreaking aging research slated for Atlanta meeting 59757 1GSA showcases groundbreaking aging research slated for Atlanta meeting 59757 2GSA showcases groundbreaking aging research slated for Atlanta meeting 59757 3GSA showcases groundbreaking aging research slated for Atlanta meeting 59757 4
...ody good,?radiologists are testing use of the dair...maging exams—with excellent results. The researche...ting of the Radiological Society of North America ...stension and enhancement as we see with the common...h-Patel, M.D., a radiology resident at St. Luke’s-...
...y one day help physicians detect cancerous tumors ...ows nanoparticles to group together inside cancero...ic signal to be detectable by a magnetic resonance... cover feature in the May issue of Angewandte Chem...ng chemistry journals. , The research, which is j...
...nto the genome of fruit flies or Drosophila ?promi...y the structure and function of virtually all the ...ther frequently studied organisms such as mice, sa... article in the current issue of the journal Scien...ently available methods because it allows you to s...
Other Biology News:Got inexpensive contrast agent? Milk plays new role in imaging 2MIT nanoparticles may help detect, treat tumors 2P(acman) takes a bite out of deciphering Drosophila DNA 2
Rat Anti-Mouse P-Selectin / CD62P Monoclonal Antibody, Unconjugated, Clone 127933 from R&D Systems
Rat Leptin from Cell Sciences
Cat IgA ELISA Kit from Bethyl Laboratories
Cat IgM ELISA Kit from Bethyl Laboratories
Biology Products: